The TREAT group has published a new study in the Journal of Nanobiotechnology titled “Thrombolytic Therapy Based on Lyophilized Platelet-Derived Nanocarriers for Ischemic Stroke.”

The study is published in collaboration with the Bionanotools group at CIQUS and demonstrates the utility of encapsulating stroke treatments in particles generated with human platelet membranes.